Eiger BioPharmaceuticals: Funding, Investors & Team (Oct 2026)
Eiger BioPharmaceuticals is a secretly held biotechnology organization that fosters a clever antiviral treatment for Hepatitis Delta, a perilous, Orphan Disease with high neglected clinical need and no supported treatment. The organization is driven by a supervisory group experienced in the turn of events and commercialization of uncommon sickness therapeutics. Its technique is predicated upon time and cost-productive medication improvement, determined to convey protected and successful treatments to patients.
Eiger BioPharmaceuticals has raised $75.0M across 1 funding round on record, the most recent a Post-IPO Debt of $75.0M announced in Jun 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eiger BioPharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Eiger BioPharmaceuticals Funding Rounds
Eiger BioPharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Eiger BioPharmaceuticals Funding Compared to Other Biotechnology Startups
Eiger BioPharmaceuticals' latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eiger BioPharmaceuticals in Biotechnology and San Carlos
Companies Similar to Eiger BioPharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Eiger BioPharmaceuticals Funding FAQs
What does Eiger BioPharmaceuticals do?
Eiger BioPharmaceuticals is a secretly held biotechnology organization that fosters a clever antiviral treatment for Hepatitis Delta, a perilous, Orphan Disease with high neglected clinical need and no supported treatment. The organization is driven by a supervisory group experienced in the turn of events and commercialization of uncommon sickness therapeutics. Its technique is predicated upon time and cost-productive medication improvement, determined to convey protected and successful treatments to patients.
How much funding has Eiger BioPharmaceuticals raised?
Eiger BioPharmaceuticals has raised $75.0M across 1 round on record. The most recent is a Post-IPO Debt of $75.0M announced in Jun 2022.
When did Eiger BioPharmaceuticals last raise funding?
Eiger BioPharmaceuticals' most recent funding round on record is a Post-IPO Debt of $75.0M, announced in Jun 2022.
Who founded Eiger BioPharmaceuticals?
FundedIQ lists Jeffrey Glenn (Founder) at Eiger BioPharmaceuticals.
Where is Eiger BioPharmaceuticals headquartered?
Eiger BioPharmaceuticals is based in San Carlos, California, United States.
How many employees does Eiger BioPharmaceuticals have?
Eiger BioPharmaceuticals is in the 11-50 employee band.
How does Eiger BioPharmaceuticals' funding compare to other Biotechnology startups?
Eiger BioPharmaceuticals' latest round of $75.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Eiger BioPharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eiger BioPharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.